Cargando…
The Dawn of a New Era in Atopic Dermatitis Treatment
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases, and the condition is typified by barrier dysfunction and immune dysregulation. Recent studies have characterized various phenotypes and endotypes of AD and elucidated the mechanism. Numerous topical and systemic nar...
Autores principales: | Yamamura, Kazuhiko, Nakahara, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605067/ https://www.ncbi.nlm.nih.gov/pubmed/36294465 http://dx.doi.org/10.3390/jcm11206145 |
Ejemplares similares
-
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
por: Tsuji, Gaku, et al.
Publicado: (2023) -
Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
por: Tsuji, Gaku, et al.
Publicado: (2023) -
Identification of a functional
DOCK8
gene polymorphism associated with atopic dermatitis
por: Kunimura, Kazufumi, et al.
Publicado: (2022) -
The New Era of Biologics in Atopic Dermatitis: A Review
por: Schneider, Simon, et al.
Publicado: (2021) -
A new era has begun: Treatment of atopic dermatitis with biologics
por: Stölzl, Dora, et al.
Publicado: (2021)